China channel feed – Endpoints News

China channel feed

Chen Yu jumps ship from Vivo Capital and goes large, allying with The Column Group on an inaugural $824M biotech crossover fund

5 years ago

Eli Lilly seeds a well-connected China neuro startup with drugs aiming at where Biogen, Voyager missed

5 years ago

Trans-Pacific bispecific player caps 'very challenging' pandemic year with $120M to gain a foothold among the giants

5 years ago

Roger Perlmutter’s latest ‘retirement’ gig opens a door to the bustling China biotech scene

5 years ago

China's YishengBio chronicles comeback story in Hong Kong IPO while plotting big moves in infectious diseases, cancer

5 years ago

Angling Pfizer, AstraZeneca jumps into commercial PD-(L)1 fight in China

5 years ago

Six years separated from a rabies vaccine scandal, China’s YishengBio grabs $130M to go big in infectious diseases, cancer

5 years ago

A month after multi-billion dollar Novartis deal, BeiGene follows up with 'reverse' deal

5 years ago

Months after shocking house arrest, Legend co-founder Frank Zhang is out on bail — though the CAR-T player has moved on

5 years ago

A synthetic lethality player emerges in China, armed with lessons on undruggable oncogene from Nobel laureate's lab

5 years ago

Innovent and Lilly win second China OK for Tyvyt in frontline NSCLC, ramping up pressure on king Keytruda

5 years ago

Nasdaq rings in its first biotech IPOs of 2021: a CAR-T specialist from China, a cancer portfolio play, and a SPAC

5 years ago

Fast-expanding Shanghai Pharma breaks ground on $1.8B biotech park focused on next-gen R&D, antibody production

5 years ago

Months after striking SHP2 deal with AbbVie, Jacobio pulls in $174M+ from Hong Kong IPO

5 years ago

A booming market propels China CRO to a $100M raise. Is an IPO next?

5 years ago

AbbVie's Covid-19 antibody partner wraps $221M Hong Kong IPO

5 years ago

Going to China? ADC Therapeutics spotlights a new way to do it with Hillhouse-backed Overland

5 years ago

'Scale and speed': Hillhouse puts its weight behind China startup eyeing cutting-edge tech from around the world

5 years ago

With plans to bring surufatinib stateside, Chi-Med vastly scales up manufacturing with new Chinese plant

5 years ago

GlaxoSmithKline R&D vet Min Li nabs $100M to launch a Bob Nelsen-backed startup focused on China’s burgeoning neuro market

5 years ago

China opens the door for biotech investors in Hong Kong to buy Shanghai stocks, and vice versa

5 years ago

Plot thickens around Legend Biotech, GenScript with founder Frank Zhang's arrest

5 years ago

Pfizer hands LianBio $70M to tag along Perceptive's China play, with an eye to beefing up regional portfolio

5 years ago

Here's a $200M China startup idea — if you can read beyond the big words

5 years ago

First page Previous page 14 15 161718 19 20 Next page Last page